Biotechnology

Quantum Cyber NV

Quantum Cyber NV released FY2026 Q1 earnings on May 15 (EST) with actual revenue of USD 0 and EPS of USD -0.4306

David Lazar Becomes Controlling Shareholder of Mainz Biomed

Mainz Biomed NV released FY2025 earnings on March 31 (EST), actual revenue USD 537.08 K (forecast USD 957 K), actual EPS USD -2.7031 (forecast USD -2.86)

Mainz Biomed NV released FY2025 9 Months Earnings on March 31 (EST), actual revenue USD 411.9K, actual EPS USD -3.0981

Mainz Biomed NV released FY2025 Q4 earnings on March 31 (EST), actual revenue USD 125.18 K (forecast USD 400 K), actual EPS USD -0.4444 (forecast USD -2)

Mainz Biomed NV released FY2025 Q3 earnings on March 31 (EST), actual revenue USD 125.18 K (forecast USD 400 K), actual EPS USD -0.4444 (forecast USD -2)

Mainz Biomed's Quantum Cyber Evaluating Quantum Computing and Cyber Defense Acquisitions

Mainz Biomed NV released FY2024 Q1 earnings on September 26 (EST), actual revenue USD 260.39 K (forecast USD 200 K), actual EPS USD -9.8646

Mainz Biomed NV released FY2025 Q1 earnings on September 26 (EST), actual revenue USD 143.36 K (forecast USD 300 K), actual EPS USD -1.3268 (forecast USD -2.8)

Mainz Biomed NV released FY2025 Q2 earnings on September 26 (EST), actual revenue USD 143.36 K (forecast USD 400 K), actual EPS USD -1.3268 (forecast USD -2.4)

Mainz Biomed NV released FY2024 Semi-Annual Earnings on September 26 (EST), actual revenue USD 520.77 K, actual EPS USD -19.7292

Mainz Biomed NV released FY2025 Semi-Annual earnings on September 26 (EST), actual revenue USD 286.72 K (forecast USD 497 K), actual EPS USD -2.6536

Mainz Biomed NV released FY2024 Q2 earnings on September 26 (EST), actual revenue USD 260.39 K (forecast USD 300 K), actual EPS USD -9.8646

Mainz Biomed NV released FY2024 Q3 earnings on March 31 (EST), actual revenue USD 186.61 K (forecast USD 250 K), actual EPS USD -3.7428

Mainz Biomed NV released FY2024 Annual Earnings on March 31 (EST), actual revenue USD 893.99 K (forecast USD 1.062 M), actual EPS USD -21.9117

MAINZ BIOMED N V released FY2023 Annual Earnings on March 31 (EST), actual revenue USD 895.48 K (forecast USD 915.5 K), actual EPS USD -64.7585

Mainz Biomed NV released FY2024 9 Months Earnings on March 31 (EST), with actual revenue of USD 707.38K and EPS of USD -23.4721

Mainz Biomed NV released FY2024 Q4 earnings on March 31 (EST), actual revenue USD 186.61 K (forecast USD 300 K), actual EPS USD -3.7428

Mainz Biomed NV released FY2022 Annual Earnings on March 31, 2025 (EST), Actual Revenue: USD 529.88K (Forecast: USD 697.5K), Actual EPS: USD -74.5537

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Wellgistics Health

Huachen AI Parking Management Tech

GeoVax Labs

Sunshine Biopharma

AIM ImmunoTech

Virax Biolabs

NextNRG

GCT Semiconductor

QUCY

Quantum Cyber N.V. has appointed Alexander Gurevich as an independent advisor and signed an Intellectual Property License Agreement with BP United Inc. for exclusive technology use. Additionally, Peter O’Rourke has been appointed as a director to enhance governance. The latest analyst rating for QUCY stock is a Buy with a $14.00 price target, though Spark's AI Analyst rates it as Neutral due to financial challenges.

Tip Ranks

Mainz Biomed NV

Quantum Cyber Appoints New Director to Strengthen Governance

Quantum Cyber N.V. (QUCY) stock rose 4.07% after forming Quantum Drones Corporation, a subsidiary focused on U.S. defense technology and autonomous systems. The unit aims to capture opportunities linked to the Pentagon's $55 billion drone budget, led by former Trump official Peter O’Rourke. This follows an exclusive agreement with BP United Inc. for autonomous drone technologies. CEO David Lazar emphasized the subsidiary's role in pursuing government contracts and advancing defense capabilities.

Fidelity

Quantum Cyber Eyes $55 Billion Pentagon Drone Opportunity With New Defense Unit

Earnings Watch

Quantum Cyber NV | 10-Q: FY2026 Q1 Revenue: USD 0

Quantum Cyber N.V. (NASDAQ: QUCY) shares fell 8% to $2.76 after a remarkable 779% rally earlier in the week. The decline follows profit-taking by short-term traders after the stock surged from 30 cents to $3.97. The spike was driven by a deal with BP United Inc. for autonomous drone technologies. Key resistance is at $3.97, while support is at 30 cents, indicating potential volatility ahead as the stock shows overbought conditions with an RSI of 92.44.

What's Going On With Quantum Cyber Stock Friday?

Quantum Cyber N.V. Launches quantum-cyber.ai Targeting Homeland Security, Autonomous Drone, & Quantum Technology Sectors | QUCY Stock News

StockTitan

Quantum Cyber N.V. Launches quantum-cyber.ai Targeting Homeland Security, Autonomous Drone, & Quantum Technology Sectors | QUCY Stock News

2 Reasons Quantum Cyber Has More Than Doubled Today

Barchart Option

2 Reasons Quantum Cyber Has More Than Doubled Today

STAA

WGRX

DOCS

IPHA

MDXH

In Thursday's pre-market session, several health care stocks experienced significant movements. Alpha Compute (ALP) surged 71.3% to $0.46, while Innate Pharma (IPHA) rose 24.24% to $1.64. Quantum Cyber (QUCY) increased by 23.88% to $1.66, and Staar Surgical (STAA) gained 21.32% to $35.67. Conversely, MDxHealth (MDXH) fell 41.0% to $1.15, and WORK Medical Tech (WOK) dropped 27.9% to $1.99. Other notable losers included Doximity (DOCS) down 23.43% to $17.91 and Wellgistics Health (WGRX) down 17.53% to $0.08. Earnings reports influenced these movements.

Quantum Cyber NV(QUCY.US)

Quantum Cyber Appoints New Director to Strengthen Governance

Quantum Cyber Eyes $55 Billion Pentagon Drone Opportunity With New Defense Unit

Quantum Cyber NV | 10-Q: FY2026 Q1 Revenue: USD 0

What's Going On With Quantum Cyber Stock Friday?

Quantum Cyber N.V. Launches quantum-cyber.ai Targeting Homeland Security, Autonomous Drone, & Quantum Technology Sectors | QUCY Stock News

2 Reasons Quantum Cyber Has More Than Doubled Today

12 Health Care Stocks Moving In Thursday's Pre-Market Session